Opportunities in the Swiss biotechnology and pharmaceutical ecosystem

Switzerland It is one of the most solid and dynamic biotechnology and pharmaceutical ecosystems in Europe, with a highly innovative environment, clear regulations, and close collaboration between companies, research centers, and administration.

This event, aimed at Asturian companies in the biotechnology and pharmaceutical sectors, will feature the participation of Dr. Carmen Walbert , specialist in international strategic development and market access, with more than 20 years of experience in leading companies in the sector such as Alnylam, Biogen, Baxter and Medtronic.

During the session, Dr. Walbert will offer direct insight into:

• How the Swiss ecosystem works and what differentiates it from other European hubs

• Regulatory and market access keys

• Real opportunities for collaboration for innovative companies

• Practical tips for generating business connections in Switzerland

•In addition, the event will allow participating companies to resolve doubts and raise specific questions.